Literature DB >> 9694322

Comparison of immunofluorescence with monoclonal antibodies and RT-PCR for the detection of human coronaviruses 229E and OC43 in cell culture.

J Sizun1, N Arbour, P J Talbot.   

Abstract

Human coronaviruses, with two known serogroups named 229E and OC43, cause up to one third of common colds and may be associated with serious diseases such as nosocomial respiratory infections, enterocolitis, pericarditis and neurological disorders. Reliable methods of detection in clinical samples are needed for a better understanding of their role in pathology. As a first step in the design of such diagnostic procedures, the sensitivities and specificities of two viral diagnostic assays were compared in an experimental cell culture model: an indirect immuno-fluorescence assay using monoclonal antibodies and reverse transcriptase-polymerase chain reaction amplification of viral RNA from infected cells. Immunofluorescence detected human coronaviruses in cells infected at a MOI as low as 10(-2) (log TCID50/ml = 4.25 for HCV-229E and 2.0 for HCV-OC43; log PFU/ml = 4.83 for HCV-229E and 1.84 for HCV-OC43) versus 10(-3) (HCV-OC43) or 10(-4) (HCV-229E) for reverse transcriptase-polymerase chain reaction amplification (log TCID50/ml = 1.75 for HCV-229E and 1.5 for HCV-OC43; log PFU/ml = 2.3 for HCV-229E and 1.34 for HCV-OC43). There were no false positive signals with other human respiratory pathogens: influenza virus, respiratory syncytial virus and adenovirus. Moreover, each assay was coronavirus serogroup-specific. These results demonstrate the potential usefulness of immunofluorescence with monoclonal antibodies and reverse transcriptase-polymerase chain reaction RNA amplification for the rapid detection of human coronaviruses in infected cell cultures. Both methods could be applied to clinical specimens for the diagnosis of human infections.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9694322      PMCID: PMC7119642          DOI: 10.1016/s0166-0934(98)00013-5

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


Introduction

Human coronaviruses (HCV) are a group of enveloped positive-stranded RNA viruses represented by two known serogroups, designated OC43 and 229E when they were first isolated (Hamre and Procknow, 1966, McIntosh et al., 1967). These ubiquitous but not well studied viruses have been associated with ∼30% of common colds in humans (Myint, 1995). Experimentally, both the 229E and OC43 prototype strains can infect human astrocytes and microglia in primary cultures (Bonavia et al., 1997) and their RNA was detected in a significant proportion of human autopsy brain samples (Stewart et al., 1992; Arbour and Talbot, unpublished results), which is consistent with their neurotropic potential. In clinical studies, various reports have associated human coronaviruses with nosocomial respiratory infections in premature newborns, as diagnosed by indirect immunofluorescence (Sizun et al., 1995), and enterocolitis in neonates with evidence of human coronaviruses shown by electron microscopy (Chany et al., 1982). Serodiagnosed human coronaviruses were also associated with exacerbations of asthma (Nicholson et al., 1993), and pericarditis (Riski and Hovi, 1980). Therefore, these viruses might be involved in diseases far more serious than mild upper respiratory tract infections. Further epidemiological studies to evaluate the pathological potential of human coronaviruses will require reliable and rapid methods for their detection in clinical samples such as nasal or tracheal aspirates, cerebrospinal fluids or other tissues. Various methods have been described for the detection of human coronaviruses. Virus isolation in cell culture is difficult, time-consuming and effective with adapted strains in specialised laboratories. Serological methods, mainly based on ELISA, were used for epidemiological studies but do not allow rapid virus identification (Kraaijeveld et al., 1980, McNaughton et al., 1983, Gill et al., 1994). Immunofluorescence with rabbit antisera was developed for the rapid detection of human coronaviruses in nasopharyngeal secretions (McIntosh et al., 1978). However, specificity of this technique was disputed because of cross-reaction between the two human coronaviruses strains, OC43 and 229E (Myint, 1995) and sensitivity was difficult to ascertain since no human coronaviruses antigen was detected in a prospective evaluation of 106 children hospitalized for respiratory tract infections. Detection of nucleic acids by reverse transcription-polymerase chain reaction (RT-PCR) was used in nasal aspirates (Myint et al., 1994). Nested PCR was apparently as sensitive as a combination of viral isolation in cell culture and serology. The aim of the current study was to compare the sensitivity and specificity of two assays, immunofluorescence (IF) with monoclonal antibodies (mAbs) and RT-PCR, for the rapid detection of human coronaviruses in an experimental cell culture model as a first step in the design of rapid diagnostic procedures in clinical samples.

Materials and methods

Viruses and cells

Susceptible cell lines (L132 from human embryonic lung and HRT-18 from a human rectal tumor) and the 229E and OC43 strains of human coronaviruses were originally obtained from the American Type Culture Collection (ATCC, Rockville, MD). Cells were grown at 37°C in a humidified atmosphere containing 5% (v/v) CO2 in Earle’s minimal essential medium (EMEM): Hank’s M199 (1:1, v/v), supplemented with 0.13% (w/v) sodium bicarbonate and 50 μg/ml gentamicin (Canadian Life Technologies, Burlington, Ont.) and fetal bovine serum (FBS) (5% (v/v) for L132 and 10% (v/v) for HRT-18 cells). Viruses were plaque-purified twice and grown on either L132 cells (HCV-229E) or HRT-18 cells (HCV-OC43), as described previously (Jouvenne et al., 1992, Mounir and Talbot, 1992). The third passage of HCV-229E in the susceptible L132 cell line, with a titer of 5.5×105 TCID50/ml (2.1×106 PFU/ml) and the fourth passage of HCV-OC43 in the susceptible HRT-18 cell line, with a titer of 5.15×105 TCID50/ml (3.6×105 PFU/ml), from laboratory stocks kept at −90°C, were used for all experiments. Human respiratory syncytial virus (RSV) (Long strain, sub-group A), human adenovirus and human influenza virus (A/USSR strain) viruses were obtained from Drs Michel Trudel, Serge Dea and Jit Arora, Armand-Frappier Institute, respectively.

Infection of cells

Approximately 2×106 cells in 2 ml EMEM: Hank’s (1:1, v/v), with 0.13% (w/v) sodium bicarbonate and 5% (v/v) FBS were mixed in a 25 cm2 tissue culture flask (Corning, Cambridge, MA) with 1 ml of virus stock diluted to give a multiplicity of infection (MOI) equal to 1 and successive logarithmic dilutions. Incubation took place in a humidified chamber incubator at 33°C and 5% (v/v) CO2 and lasted 24 h for HCV-229E and 48 h for HCV-OC43 (previously determined optimal times). At the end of the incubation period, cell-free supernatant was removed. Cell monolayers were washed twice in phosphate buffered saline (PBS), dissociated with 0.25% (w/v) trypsin (Canadian Life Technologies) for L132 cells and 0.05% (w/v) trypsin plus 0.53 mM EDTA (Canadian Life Technologies) for HRT-18 cells, and washed in PBS (7 min, 1200 rpm, 340×g in a Beckman GS-6R centrifuge). Cells were resuspended in 3 ml PBS. A total of 25 μl of the infected cell suspension was deposited onto each well of a 12-well glass slide (Flow, ICN Biomedical, Mississauga, Ont.), dried in a laminar flow hood and fixed in acetone at −20°C for 30 min. Slides, supernatants and residual cell suspensions were used immediately or stored at −70°C. Negative controls consisted of non-infected cells.

Indirect immunofluorescence assay

Virus-specific mAbs produced in our laboratory by standard hybridoma technology were used in an indirect immunofluorescence (IF) test on cells infected at various MOIs with either HCV-229E or HCV-OC43. We used a mouse IgG1 mAb (5–11H.6) for HCV-229E detection and a mouse IgG1 mAb (1–10C.1) for HCV-OC43 detection. These two mAbs were shown by Western immunoblotting and radioimmunoprecipitation to recognise the surface S glycoprotein of HCV-229E and HCV-OC43, respectively (data not shown). Primary antibody at a 1/100 dilution was added to thawed slides and incubated for 1 h at 37°C. This was followed by three washes in PBS and addition of the fluorescein-conjugated mouse-specific goat secondary antibody (Cappel, Durham, NC) and incubation for 30 min at 37°C. After three washes in PBS, slides were stained with Evans Blue (0.003% (w/v) in distilled water) and mounted with glycerol:PBS (9:1). Slides were observed immediately with a Leica fluorescence microscope or stored at −20°C for later observation. A monolayer was scored negative if it contained no cells with typical fluorescence in ten fields containing at least 30 cells each. An isotype control antibody consisted of a mAb against an unrelated plant virus (Robbins et al., 1994).

Immunoperoxidase assay for infectious virus

Infectious virus titers of samples used for evaluation of diagnostic techniques were measured using an immunoperoxidase method. Susceptible cells (L132 or HRT-18) at 70% confluence were inoculated with logarithmic dilutions of samples in a 96-well Linbro plate (Flow, McLean, VA). After 4–5 days of incubation in a humidified chamber at 33°C and 5% (v/v) CO2, the cells were washed with PBS and fixed with 0.3% (v/v) hydrogen peroxide (Sigma) in methanol for 30 min. After washing with PBS, they were incubated for 2 h at 33°C and 5% (v/v) CO2 with an appropriate antiviral antibody (5–11H.6 for HCV-229E and 1–10C.1 for HCV-OC43, with control reactions using the 229E-specific mAb on OC43-infected cells and the OC43-specific mAb on 229E-infected cells). The cells were then washed five times with PBS and horseradish peroxidase-conjugated goat anti-mouse immunoglobulins (KPL, Gaithersburg, Maryland) were added and incubated for 2 h at 37°C without CO2. Bound antibodies were detected by incubation with 0.025% (w/v) 3,3′-diaminobenzidine-tetrahydrochloride (Bio-Rad, Richmond, CA) and 0.01% (v/v) hydrogen peroxide (Sigma) in PBS. The chromogenic reaction was stopped with deionized water. Infectious virus titers were calculated by the Karber method (Payment and Trudel, 1989). Negative and positive controls consisted of non-infected cells and cells infected with the appropriate virus stock, respectively.

RT-PCR

To obtain total cellular RNA from infected and controls cells, 20 μl of the cell suspension was mixed with 80 μl of PBS, spun down at 5900×g for 10 min (Eppendorf centrifuge, Model 5415C) and resuspended in 150 μl of 0.1% (v/v) diethyl pyrocarbonate (DEPC; Sigma). The solution was boiled for 5 min, cellular debris eliminated by centrifugation for 2 min at 12 000×g and the supernatant used immediately or stored at −90°C (Bonavia et al., 1997). The oligonucleotide primer pairs used for RT-PCR are described in Table 1 . The RT-PCR protocol was used as described previously (Stewart et al., 1992).
Table 1

Primers for RT-PCR amplification of HCV RNA

HCVPrimers
229Ea5′-TCTGCCAAGAGTCTTGCTCG-3′ (E7, sense)
5′-AGCATAGCAGCTGTTGACGG-3′ (E9, antisense)



OC43b5′-CCCAAGCAAACTGCTACCTCTCAG-3′ (O1, sense)
5′-GTAGACTCCGTCAATATCGGTGCC-3′ (O3, antisense)

Amplified region corresponding to nucleotides 819–1054 of the nucleocapsid protein gene (Schreiber et al., 1989, Bonavia et al., 1997).

bAmplified region corresponding to nucleotides 215–520 of the nucleocapsid protein gene (Kamahora et al., 1989, Stewart et al., 1992).

Primers for RT-PCR amplification of HCV RNA Amplified region corresponding to nucleotides 819–1054 of the nucleocapsid protein gene (Schreiber et al., 1989, Bonavia et al., 1997). bAmplified region corresponding to nucleotides 215–520 of the nucleocapsid protein gene (Kamahora et al., 1989, Stewart et al., 1992).

Results

Sensitivity of virus detection

Using IF, we were able to detect human coronaviruses antigens in viral preparations that showed viral titers of either 4.25 (HCV-229E) or 2.0 (HCV-OC43) log TCID50/ml, as monitored by an immunoperoxidase assay that detects infectious virions in cells infected with the sample to be tested (Table 2 ). This corresponds to 4.83 and 1.84 log PFU/ml, respectively. On the other hand, RT-PCR was more sensitive for both viruses than IF since it allowed the detection of human coronaviruses in preparations containing as low as 1.75 or 1.5 log TCID50/ml of HCV-229E or HCV-OC43, respectively (Fig. 1 ). This corresponds to 2.3 and 1.34 log PFU/ml, respectively. Importantly, the RT-PCR assay did not detect input virions, since RT-PCR performed on RNA extracted from cells inoculated with virus at 4°C (where there is no viral penetration into cells) were negative (data not shown). However, it is not possible to evaluate the sensitivity of the RT-PCR assay in terms of the amount of viral RNA since its proportion in total cellular RNA is not known.
Table 2

Detection of human coronaviruses in cell culture by IF and RT-PCR

HCVMOIaInfectious viral titer (log TICD50/ml)IF mAb 5–11H.6IF mAb 1–10C.1RT-PCR primers E7–E9RT-PCR primers O1–O3
229E14.0++
10−14.75++
10−24.25++
10−32.75+
10−41.75+
10−5<0.5



OC4310−13.0++
10−22.0++
10−31.5+
10−4<0.5
10−5<0.5

Susceptible cells were infected at the indicated MOI to yield virus preparations with the indicated infectious viral titers measured by an immunoperoxidase assay. These viral preparations were used for IF using mAbs 5–10H.6 (229E-specific) or 1–10C.1 (OC43-specific) or RT-PCR with primer pairs E7–E9 (229E-specific) or O1–O3 (OC43-specific).

Fig. 1

Results of RT-PCR detection of human coronaviruses. Panel A: RT-PCR for HCV-OC43: lanes 1–5, HRT-18 cells infected with logarithmic dilutions of HCV-OC43 (log TCID50/ml=3.0, 2.0, 1.5, <0.5, <0.5, respectively); lanes 6–8, cells infected with either human respiratory syncytial virus, influenza virus or adenovirus, respectively; lane 9, positive control with HCV-OC43 RNA; lane 10, L-132 cells infected with HCV-229E; lanes 11 and 12, negative controls (RT and PCR, respectively). Panel B: RT-PCR for HCV-229E; lanes 1–5, L-132 cells infected with logarithmic dilutions of HCV-229E (log TCID50/ml=4.75, 4.25, 2.75, 1.75, <0.5, respectively); lanes 6–8, cells infected with either human respiratory syncytial virus, influenza virus or adenovirus, respectively; lane 9: positive control with HCV-229E RNA; lane 10: HRT-18 cells infected with HCV-OC43, lanes 11 and 12, negative controls (RT and PCR, respectively).

Detection of human coronaviruses in cell culture by IF and RT-PCR Susceptible cells were infected at the indicated MOI to yield virus preparations with the indicated infectious viral titers measured by an immunoperoxidase assay. These viral preparations were used for IF using mAbs 5–10H.6 (229E-specific) or 1–10C.1 (OC43-specific) or RT-PCR with primer pairs E7–E9 (229E-specific) or O1–O3 (OC43-specific). Results of RT-PCR detection of human coronaviruses. Panel A: RT-PCR for HCV-OC43: lanes 1–5, HRT-18 cells infected with logarithmic dilutions of HCV-OC43 (log TCID50/ml=3.0, 2.0, 1.5, <0.5, <0.5, respectively); lanes 6–8, cells infected with either human respiratory syncytial virus, influenza virus or adenovirus, respectively; lane 9, positive control with HCV-OC43 RNA; lane 10, L-132 cells infected with HCV-229E; lanes 11 and 12, negative controls (RT and PCR, respectively). Panel B: RT-PCR for HCV-229E; lanes 1–5, L-132 cells infected with logarithmic dilutions of HCV-229E (log TCID50/ml=4.75, 4.25, 2.75, 1.75, <0.5, respectively); lanes 6–8, cells infected with either human respiratory syncytial virus, influenza virus or adenovirus, respectively; lane 9: positive control with HCV-229E RNA; lane 10: HRT-18 cells infected with HCV-OC43, lanes 11 and 12, negative controls (RT and PCR, respectively).

Specificity of virus detection

The mAbs showed a characteristic cytoplasmic fluorescence in human coronaviruses-infected cells (Fig. 2 ), but not in non-infected cells (data not shown). Control respiratory human viruses (influenza virus, adenovirus and respiratory syncytial virus) yielded negative results by IF (data not shown). Each mAb was specific for one human coronaviruses serogroup since no fluorescence was observed when the 229E-specific mAb was used on OC43-infected cells or when the OC43-specific mAb was used on 229E-infected cells (Fig. 2). There was a good correlation between results obtained by IF and by RT-PCR.
Fig. 2

Detection of human coronaviral antigens by indirect immunofluorescence on infected cells. Panels A and B: HRT-18 cells infected with HCV-OC43; Panels C and D: L132 cells infected with HCV-229E. Immunodetection was achieved with mAbs to either HCV-229E (5–11H.6: panels A and C), or HCV-OC43 (1–10C.1: panels B and D). Magnification: ×1200.

Detection of human coronaviral antigens by indirect immunofluorescence on infected cells. Panels A and B: HRT-18 cells infected with HCV-OC43; Panels C and D: L132 cells infected with HCV-229E. Immunodetection was achieved with mAbs to either HCV-229E (5–11H.6: panels A and C), or HCV-OC43 (1–10C.1: panels B and D). Magnification: ×1200.

Discussion

Two methods for the detection of human coronaviruses strains 229E and OC43 were compared: indirect immunofluorescence with virus-specific mAbs and RT-PCR. A cell culture experimental model was used rather than clinical samples since assays undertaken on human samples do not allow precise analysis of the sensitivities and specificities of human coronaviruses detection methods. This is because the number of infectious virus particles in coronavirus-containing secretions is unknown. Moreover, reference methods such as the culture of clinical samples are difficult to carry out. Finally, possible double viral infections may adversely affect studies of specificity (Valenti et al., 1982, Wilson et al., 1989). Indirect immunofluorescence is used routinely for the diagnosis of viral respiratory infections and we use it routinely to evaluate human coronaviruses infections. The results of this study confirm the appropriate sensitivity of this technique. Indeed, IF allowed the detection of human coronaviruses in cell suspensions with infectious viral titers of 4.25 log TCID50/ml for HCV-229E and 2.0 log TCID50/ml for HCV-OC43. No false positive signals were observed with human influenza virus, human respiratory syncytial virus and human adenovirus. Importantly, each mAb was human coronaviruses serogroup-specific. Polyclonal antibodies used in a previous study did not show such serogroup specificity since OC43-infected cells yielded a positive signal when the 229E-specific antibody was used (McIntosh et al., 1978). Epidemiological studies have shown that patients infected with the 229E strain of human coronaviruses rarely have circulating antibodies against the OC43 strain (Kapikian et al., 1969). Therefore, it would be interesting to distinguish between HCV-229E and HCV-OC43 during a clinical study and the serogroup-specific tests we describe would be useful for that purpose. The RT-PCR technique was as specific and more sensitive than IF since it allowed the detection of human coronaviruses in cell suspensions with viral titers as low as 1.75 log TCID50/ml for HCV-229E and 1.5 log TCID50/ml for HCV-OC43. In the only other published report on the detection of human coronaviruses by RT-PCR, the sensitivity of a nested PCR technique was compared in clinical samples to two techniques, ELISA and cell culture, the latter being only available for HCV-229E (Myint et al., 1994). The PCR technique appeared more sensitive than either cell culture or ELISA, but less than the two associated techniques. Specificity in clinical use was difficult to ascertain because of possible dual infections (human coronaviruses with either rhinovirus or influenza virus). These investigations used the classical single-step RNA extraction of Chomczynski and Sacchi (1989), which requires 3–4 h to execute, and they undertook two PCR amplification rounds. It would be difficult to obtain results within 1 day using this protocol. A simple cells lysis with DEPC-treated water and elimination of proteins and cell walls allowed us to perform RT-PCR for several samples very rapidly. The technique we used would be more appropriate for treating a large number of human samples containing few cells. We have already reported the use of the RT-PCR technique with clinical samples (Stewart et al., 1992, Bonavia et al., 1997). Interestingly, the immunoperoxydase assay we used to validate the quantification of virus to be detected by IF and RT-PCR appeared more sensitive than these two techniques, most likely because of the amplification afforded by another round of virus replication in susceptible cells. However, such an assay is not suitable for clinical applications since the results are only obtained after several days and require viral infection, which works well with cell culture-adapted prototype strains but may not be possible with field virus isolates. The results of the current study demonstrate the potential usefulness of mAb-based IF and RT-PCR for the detection of human coronaviruses. Interestingly, it was recently emphasized that nucleic acid amplification techniques for the diagnosis of respiratory tract infections in the clinical laboratory are warranted when rapid conventional methods are not available, which is the case for coronaviruses, as it is for rhinoviruses and enteroviruses (Ieven and Goossens, 1997). The results of the current study show the feasibility of such a technique for the rapid detection of human coronaviruses. Both IF and RT-PCR techniques presented in the current study showed good sensitivity and specificity for the two known human coronaviruses serogroups
  23 in total

1.  Genetic mapping of turnip mosaic virus resistance in Lactuca sativa.

Authors:  M A Robbins; H Witsenboer; R W Michelmore; J F Laliberte; M G Fortin
Journal:  Theor Appl Genet       Date:  1994-11       Impact factor: 5.699

2.  Sequence analysis of the membrane protein gene of human coronavirus OC43 and evidence for O-glycosylation.

Authors:  S Mounir; P J Talbot
Journal:  J Gen Virol       Date:  1992-10       Impact factor: 3.891

3.  A concurrent epidemic of respiratory syncytial virus and echovirus 7 infections in an intensive care nursery.

Authors:  C W Wilson; D K Stevenson; A M Arvin
Journal:  Pediatr Infect Dis J       Date:  1989-01       Impact factor: 2.129

4.  Association of coronavirus infection with neonatal necrotizing enterocolitis.

Authors:  C Chany; O Moscovici; P Lebon; S Rousset
Journal:  Pediatrics       Date:  1982-02       Impact factor: 7.124

5.  Respiratory viruses and exacerbations of asthma in adults.

Authors:  K G Nicholson; J Kent; D C Ireland
Journal:  BMJ       Date:  1993-10-16

6.  Diagnosis of human coronavirus infection by immunofluorescence: method and application to respiratory disease in hospitalized children.

Authors:  K McIntosh; J McQuillin; S E Reed; P S Gardner
Journal:  J Med Virol       Date:  1978       Impact factor: 2.327

7.  Isolation from man of "avian infectious bronchitis virus-like" viruses (coronaviruses) similar to 229E virus, with some epidemiological observations.

Authors:  A Z Kapikian; H D James; S J Kelly; J H Dees; H C Turner; K McIntosh; H W Kim; R H Parrott; M M Vincent; R M Chanock
Journal:  J Infect Dis       Date:  1969-03       Impact factor: 5.226

8.  Sequence analysis of the nucleocapsid protein gene of human coronavirus 229E.

Authors:  S S Schreiber; T Kamahora; M M Lai
Journal:  Virology       Date:  1989-03       Impact factor: 3.616

9.  Sequence analysis of human coronavirus 229E mRNAs 4 and 5: evidence for polymorphism and homology with myelin basic protein.

Authors:  P Jouvenne; S Mounir; J N Stewart; C D Richardson; P J Talbot
Journal:  Virus Res       Date:  1992-02       Impact factor: 3.303

10.  Coronavirus infections of man associated with diseases other than the common cold.

Authors:  H Riski; T Hovi
Journal:  J Med Virol       Date:  1980       Impact factor: 2.327

View more
  24 in total

1.  Survival of human coronaviruses 229E and OC43 in suspension and after drying onsurfaces: a possible source ofhospital-acquired infections.

Authors:  J Sizun; M W Yu; P J Talbot
Journal:  J Hosp Infect       Date:  2000-09       Impact factor: 3.926

2.  In vitro detection of apoptosis in monocytes/macrophages infected with human coronavirus.

Authors:  Arlene R Collins
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

3.  HCoV-229E infects and activates monocytes.

Authors:  Marc Desforges; Tina Miletti; Mylène Gagnon; Pierre J Talbot
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

4.  Acute and persistent infection of human neural cell lines by human coronavirus OC43.

Authors:  N Arbour; G Côté; C Lachance; M Tardieu; N R Cashman; P J Talbot
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

5.  Persistent infection of human oligodendrocytic and neuroglial cell lines by human coronavirus 229E.

Authors:  N Arbour; S Ekandé; G Côté; C Lachance; F Chagnon; M Tardieu; N R Cashman; P J Talbot
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

Review 6.  Mass screening is a key component to fight against SARS-CoV-2 and return to normalcy.

Authors:  Zhaomin Feng; Yi Zhang; Yang Pan; Daitao Zhang; Lei Zhang; Quanyi Wang
Journal:  Med Rev (Berl)       Date:  2022-04-28

Review 7.  Detection of respiratory viruses by molecular methods.

Authors:  James B Mahony
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

8.  Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients.

Authors:  Giuseppe Gerna; Giulia Campanini; Francesca Rovida; Elena Percivalle; Antonella Sarasini; Antonietta Marchi; Fausto Baldanti
Journal:  J Med Virol       Date:  2006-07       Impact factor: 2.327

Review 9.  COVID-19 Infection Diagnosis: Potential Impact of Isothermal Amplification Technology to Reduce Community Transmission of SARS-CoV-2.

Authors:  Ameh S James; John I Alawneh
Journal:  Diagnostics (Basel)       Date:  2020-06-11

10.  Outbreaks of human coronavirus in a pediatric and neonatal intensive care unit.

Authors:  Arnaud Gagneur; Sophie Vallet; Pierre J Talbot; Marie-Christine Legrand-Quillien; Bertrand Picard; Christopher Payan; Jacques Sizun
Journal:  Eur J Pediatr       Date:  2008-03-12       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.